BACKGROUND: Limited information is available about potentially changing and contemporary trends in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction. The objectives of our study were to examine 3-decade-long trends (1975 to 2005) in the incidence rates of cardiogenic shock complicating acute myocardial infarction, patient characteristics and treatment practices associated with this clinical complication, and hospital death rates in residents of a large central New England community hospitalized with acute myocardial infarction at all area medical centers. METHODS AND RESULTS: The study population consisted of 13 663 residents of the Worcester (Mass) metropolitan area hospitalized with acute myocardial infarction at all greater Worcester medical centers during 15 annual periods between 1975 and 2005. Overall, 6.6% of patients developed cardiogenic shock during their index hospitalization. The incidence rates of cardiogenic shock remained stable between 1975 and the late 1990s but declined in an inconsistent manner thereafter. Patients in whom cardiogenic shock developed had a significantly greater risk of dying during hospitalization (65.4%) than those who did not develop cardiogenic shock (10.6%) (P<0.001). Encouraging increases in hospital survival in patients with cardiogenic shock, however, were observed from the mid-1990s to our most recent study years. Several patient demographic and clinical characteristics were associated with an increased risk for developing cardiogenic shock. CONCLUSIONS: Our findings indicate improving trends in the hospital prognosis associated with cardiogenic shock. Given the high death rates associated with this clinical complication, monitoring future trends in the incidence and death rates and the factors associated with an increased risk for developing cardiogenic shock remains warranted.
BACKGROUND: Limited information is available about potentially changing and contemporary trends in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction. The objectives of our study were to examine 3-decade-long trends (1975 to 2005) in the incidence rates of cardiogenic shock complicating acute myocardial infarction, patient characteristics and treatment practices associated with this clinical complication, and hospital death rates in residents of a large central New England community hospitalized with acute myocardial infarction at all area medical centers. METHODS AND RESULTS: The study population consisted of 13 663 residents of the Worcester (Mass) metropolitan area hospitalized with acute myocardial infarction at all greater Worcester medical centers during 15 annual periods between 1975 and 2005. Overall, 6.6% of patients developed cardiogenic shock during their index hospitalization. The incidence rates of cardiogenic shock remained stable between 1975 and the late 1990s but declined in an inconsistent manner thereafter. Patients in whom cardiogenic shock developed had a significantly greater risk of dying during hospitalization (65.4%) than those who did not develop cardiogenic shock (10.6%) (P<0.001). Encouraging increases in hospital survival in patients with cardiogenic shock, however, were observed from the mid-1990s to our most recent study years. Several patient demographic and clinical characteristics were associated with an increased risk for developing cardiogenic shock. CONCLUSIONS: Our findings indicate improving trends in the hospital prognosis associated with cardiogenic shock. Given the high death rates associated with this clinical complication, monitoring future trends in the incidence and death rates and the factors associated with an increased risk for developing cardiogenic shock remains warranted.
Authors: M E Hands; J D Rutherford; J E Muller; G Davies; P H Stone; C Parker; E Braunwald Journal: J Am Coll Cardiol Date: 1989-07 Impact factor: 24.094
Authors: Keith A A Fox; Philippe Gabriel Steg; Kim A Eagle; Shaun G Goodman; Frederick A Anderson; Christopher B Granger; Marcus D Flather; Andrzej Budaj; Ann Quill; Joel M Gore Journal: JAMA Date: 2007-05-02 Impact factor: 56.272
Authors: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs Journal: Circulation Date: 2004-08-03 Impact factor: 29.690
Authors: R J Goldberg; J M Gore; J S Alpert; V Osganian; J de Groot; J Bade; Z Chen; D Frid; J E Dalen Journal: N Engl J Med Date: 1991-10-17 Impact factor: 91.245
Authors: Jane S Saczynski; Darleen Lessard; Frederick A Spencer; Jerry H Gurwitz; Joel M Gore; Jorge Yarzebski; Robert J Goldberg Journal: Am J Med Date: 2010-11 Impact factor: 4.965
Authors: Mayra Tisminetzky; David D McManus; Nathaniel Erskine; Jane S Saczynski; Jorge Yarzebski; Edgard Granillo; Joel Gore; Robert J Goldberg Journal: Am J Med Date: 2015-02-03 Impact factor: 4.965
Authors: Han-Yang Chen; Joel M Gore; Kate L Lapane; Jorge Yarzebski; Sharina D Person; Jerry H Gurwitz; Catarina I Kiefe; Robert J Goldberg Journal: Am J Cardiol Date: 2015-04-06 Impact factor: 2.778